von Tobias Borgers | Sep. 17, 2021 | Continuous Manufacturing
Reading Time: 3 minutesPharmaceutical manufacturing is advancing rapidly as scientists and engineers develop new solutions and medications to improve patient health outcomes. The entire pharmaceutical industry is upping its technology game to keep up with the evolving...
von Tobias Borgers | Sep. 17, 2021 | Fette
Supply Chain Mehr Transparenz in die Lieferkette – Ist Blockchain die Lösung? Schnelle Reaktionen auf dynamische Ereignisse, bessere Planbarkeit und höhere Liefersicherheit versprechen Plattform-Lösungen auf Blockchain-Basis. Dank Transparenz in der Lieferkette lässt...
von Tobias Borgers | Sep. 17, 2021 | Continuous Manufacturing
The global population’s health has always depended on the pharmaceutical industry, but never so pointedly as it did at the height of the coronavirus pandemic. The world needed inoculations on a massive scale, and it needed them yesterday. Rarely is so much asked of an...
von Tobias Borgers | Sep. 14, 2021 | Boehringer
INGELHEIM, Germany & HOUSTON–(BUSINESS WIRE)–Boehringer Ingelheim and The University of Texas MD Anderson Cancer Center today announced the extension and expansion of their joint Virtual Research and Development Center (VRDC) to explore new molecules...
von Tobias Borgers | Sep. 14, 2021 | Abbvie
Copenhagen, Denmark; North Chicago, Ill. – Genmab A/S (Nasdaq: GMAB) and AbbVie (NYSE: ABBV) announced The Lancet published the results of the dose escalation part of the phase 1/2 EPCORE NHL-1 first-in-human (FIH) dose escalation and cohort expansion clinical...
